News

Clara Chan, MD, shares surgical pearls for neurotrophic keratopathy and explores new pathways through neurotisation

The approval marks the first new steroid on the US ophthalmic market in more than 15 years

A longitudinal, AI-based approach to fluid quantification

Mentorship, leadership and addressing bias are key areas for improvement

The algorithms could provide major accessibility improvements and cost savings to underdeveloped regions

Penetrating keratoplasty remains a popular choice for certain patients

The kidney and eye are structurally similar and the diseases of the organs may present via common pathways

The authors suggested genetic mutation may relax the body’s defences and allow harmful bacteria to reach the eye

The Retinopathy of Prematurity (ROP) Education and Support Programme is part of ROP Awareness Week, recognised from 26 February to 3 March

Innovative therapies scale up to meet needs of a growing patient population

Patient age is significant in the long-term effect of orthokeratology lenses

Optical coherence tomography angiography could also identify patients at risk of disease progression

The company made its CE Mark announcement during the ESCRS Winter Meeting

Physicians explore how other specialties adopt and integrate remote monitoring

The Phase 2/3 VISTA trial for AGTC-501 in XLRP is expected to begin in in the first half of 2024

The company, headquarted in New York and London, named OK-101 as the first IND clearance granted by the FDA for a drug to begin clinical studies specifically to treat NCP

The technology has potential for applications in contact lenses and intraocular implants

According to the company, the patent further protects Iridex’s intellectual property encompassing laser systems in ophthalmology and related fields

An investment from the Sir Jules Thorn Charitable Trust will support a state-of-the-art building, opening in 2027

Toku’s AI technology, CLAiR, provides fast, accurate, non-invasive cardiovascular disease (CVD) risk assessments using standard retinal images

How this treatment paradigm could change ocular cell therapy

Dr Baruch Kuppermann discusses interim results from the first in-human Phase 2 RIPPLE-1 Trial of a dexamethasone implant for diabetic macular oedema and retinal vein occlusion.

Robyn Guymer, MBBS, PhD, reported the Voyager study’s preliminary data at the 2024 Angiogenesis, Exudation, and Degeneration conference

EODM may be an ideal candidate for development of complement gene therapy due to the high-impact genetic variants

Researchers aimed to develop a translational map to understand how advanced imaging biomarkers manifest in typical diagnostic imaging

Kiora Pharmaceuticals and Théa Open Innovation will develop and commercialise KIO-301 for the treatment of inherited retinal diseases

Many options with one single Nd:YAG laser

Enhanced detection and diagnosis of common and severe diseases

An in-depth case study conversation